Strikingly, CD101, a type I transmembrane glycoprotein, was highly co-expressed with CD103 in both the tumor and tumor adjacent skin but not in the TdLN, suggesting that CD101 as a potential marker to identify TRM-like cells (Figure 3D). The gene discussed is CD101; the disease is neoplasm.